Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Hania Kébir(University of Pennsylvania), Alexandre Prat(Université de Montréal), Burkhard Becher(University of Zurich), Igal Ifergan(University of Cincinnati), Aurore Dodelet-Devillers(Hôpital Notre-Dame), Romain Cayrol(Université de Montréal), Fabrizio Giuliani(University of Alberta), Nathalie Arbour(Centre Hospitalier de l’Université de Montréal), Monique Bernard(Centre National de la Recherche Scientifique), Katharina Kreymborg(University Hospital of Zurich)
Cited by 1,750
Related Papers
The Blood–Brain Barrier
|Cold Spring Harbor Perspectives in Biology|2015|3.2k
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
|European Journal of Immunology|2019|1k
The Role of Inflammation in Depression and Fatigue
|Frontiers in Immunology|2019|651
Guidelines for the use of flow cytometry and cell sorting in immunological studies <sup>*</sup>
|European Journal of Immunology|2017|554
New insights into IL-12-mediated tumor suppression
|Cell Death and Differentiation|2014|550